{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:24:09Z","timestamp":1790630649676,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.canlet.2021.11.017","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T09:06:12Z","timestamp":1637312772000},"page":"76-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Tumor-derived miR-378a-3p-containing extracellular vesicles promote osteolysis by activating the Dyrk1a\/Nfatc1\/Angptl2 axis for bone metastasis"],"prefix":"10.1016","volume":"526","author":[{"given":"Jialin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxing","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixiang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baijun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Qiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Xiang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2021.11.017_bib1","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3389\/fonc.2014.00364","article-title":"The host microenvironment influences prostate cancer invasion, systemic spread, bone colonization, and osteoblastic metastasis","volume":"4","author":"Ganguly","year":"2014","journal-title":"Frontiers in oncology"},{"key":"10.1016\/j.canlet.2021.11.017_bib2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/jnci\/dji002","article-title":"Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors","volume":"97","author":"Brown","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2021.11.017_bib3","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1172\/JCI11685","article-title":"Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone","volume":"107","author":"Zhang","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2021.11.017_bib4","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/jcb.10662","article-title":"Prostate cancer bone metastases promote both osteolytic and osteoblastic activity","volume":"91","author":"Keller","year":"2004","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.canlet.2021.11.017_bib5","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.urolonc.2007.11.004","article-title":"Osteoclast targeted therapy for prostate cancer: bisphosphonates and beyond","volume":"26","author":"Smith","year":"2008","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.canlet.2021.11.017_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/s41556-018-0250-9","article-title":"Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication","volume":"21","author":"Mathieu","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2021.11.017_bib7","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41571-018-0036-9","article-title":"Extracellular vesicles in cancer - implications for future improvements in cancer care","volume":"15","author":"Xu","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2021.11.017_bib8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1476-4598-13-42","article-title":"High calcium concentration in bones promotes bone metastasis in renal cell carcinomas expressing calcium-sensing receptor","volume":"13","author":"Joeckel","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2021.11.017_bib9","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1038\/s41388-019-0736-3","article-title":"Prostate cancer promotes a vicious cycle of bone metastasis progression through inducing osteocytes to secrete GDF15 that stimulates prostate cancer growth and invasion","volume":"38","author":"Wang","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2021.11.017_bib10","doi-asserted-by":"crossref","first-page":"878","DOI":"10.7150\/thno.49186","article-title":"Discovery of extracellular vesicles derived miR-181a-5p in patient's serum as an indicator for bone-metastatic prostate cancer","volume":"11","author":"Wang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2021.11.017_bib11","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ccr.2013.09.008","article-title":"Tumor-induced osteoclast miRNA changes as regulators and biomarkers of osteolytic bone metastasis","volume":"24","author":"Ell","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2021.11.017_bib12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12033-010-9244-y","article-title":"Development of chimeric gene regulators for cancer-specific gene therapy with both transcriptional and translational targeting","volume":"45","author":"Fang","year":"2010","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.canlet.2021.11.017_bib13","doi-asserted-by":"crossref","DOI":"10.3791\/55234","article-title":"Stimulation of Notch signaling in mouse osteoclast precursors","author":"Kaur","year":"2017","journal-title":"JoVE : JoVE"},{"key":"10.1016\/j.canlet.2021.11.017_bib14","doi-asserted-by":"crossref","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Th\u00e9ry","year":"2018","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.canlet.2021.11.017_bib15","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2021.11.017_bib16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2307\/2532042","article-title":"A general class of nonparametric tests for survival analysis","volume":"45","author":"Jones","year":"1989","journal-title":"Biometrics"},{"key":"10.1016\/j.canlet.2021.11.017_bib17","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"key":"10.1016\/j.canlet.2021.11.017_bib18","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.jhep.2014.02.025","article-title":"Monoamine oxidase A suppresses hepatocellular carcinoma metastasis by inhibiting the adrenergic system and its transactivation of EGFR signaling","volume":"60","author":"Li","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2021.11.017_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2199-15-1","article-title":"MicroRNA miR-378 promotes BMP2-induced osteogenic differentiation of mesenchymal progenitor cells","volume":"15","author":"Hupkes","year":"2014","journal-title":"BMC Mol. Biol."},{"key":"10.1016\/j.canlet.2021.11.017_bib20","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.7150\/ijbs.46966","article-title":"The role of monoamine oxidase A in HPV-16 E7-induced epithelial-mesenchymal transition and HIF-1\u03b1 protein accumulation in non-small cell lung cancer cells","volume":"16","author":"Huang","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.canlet.2021.11.017_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.semcancer.2014.04.009","article-title":"Sorting it out: regulation of exosome loading","volume":"28","author":"Villarroya-Beltri","year":"2014","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2021.11.017_bib22","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1038\/ncomms3980","article-title":"Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs","volume":"4","author":"Villarroya-Beltri","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2021.11.017_bib23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41413-020-00105-1","article-title":"Molecular mechanisms and clinical management of cancer bone metastasis","volume":"8","author":"Wang","year":"2020","journal-title":"Bone Res"},{"key":"10.1016\/j.canlet.2021.11.017_bib24","doi-asserted-by":"crossref","first-page":"33343","DOI":"10.1074\/jbc.M109.042234","article-title":"Negative feedback Inhibition of NFATc1 by DYRK1A regulates bone homeostasis","volume":"284","author":"Lee","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2021.11.017_bib25","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bone.2011.04.003","article-title":"The small molecule harmine regulates NFATc1 and Id2 expression in osteoclast progenitor cells","volume":"49","author":"Egusa","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.canlet.2021.11.017_bib26","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.addr.2015.11.017","article-title":"Heterogeneity of tumor cells in the bone microenvironment: mechanisms and therapeutic targets for bone metastasis of prostate or breast cancer","volume":"99","author":"Futakuchi","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.canlet.2021.11.017_bib27","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1158\/0008-5472.CAN-11-3878","article-title":"Tumor cell-derived angiopoietin-like protein ANGPTL2 is a critical driver of metastasis","volume":"72","author":"Endo","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2021.11.017_bib28","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nm.2753","article-title":"Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET","volume":"18","author":"Peinado","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2021.11.017_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186680","article-title":"Extracellular vesicles in bone metastasis: key players in the tumor microenvironment and promising therapeutic targets","volume":"21","author":"Tamura","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2021.11.017_bib30","article-title":"MiR-378a-3p is critical for burkitt lymphoma cell growth","volume":"12","author":"Niu","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2021.11.017_bib31","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.canlet.2018.07.016","article-title":"LncRNA-p23154 promotes the invasion-metastasis potential of oral squamous cell carcinoma by regulating Glut1-mediated glycolysis","volume":"434","author":"Wang","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2021.11.017_bib32","doi-asserted-by":"crossref","first-page":"8834","DOI":"10.7150\/thno.45158","article-title":"LXR activation potentiates sorafenib sensitivity in HCC by activating microRNA-378a transcription","volume":"10","author":"Lin","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2021.11.017_bib33","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ccell.2017.02.003","article-title":"MAOA-dependent activation of shh-IL6-RANKL signaling Network promotes prostate cancer metastasis by engaging tumor-stromal cell interactions","volume":"31","author":"Wu","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2021.11.017_bib34","doi-asserted-by":"crossref","first-page":"e381","DOI":"10.1002\/ctm2.381","article-title":"Caveolin-1-driven membrane remodelling regulates hnRNPK-mediated exosomal microRNA sorting in cancer","volume":"11","author":"Robinson","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.canlet.2021.11.017_bib35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13059-018-1604-0","article-title":"Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5","volume":"20","author":"Qin","year":"2019","journal-title":"Genome Biol."},{"key":"10.1016\/j.canlet.2021.11.017_bib36","doi-asserted-by":"crossref","first-page":"5642","DOI":"10.7150\/thno.34813","article-title":"Chronic myelogenous leukemia cells remodel the bone marrow niche via exosome-mediated transfer of miR-320","volume":"9","author":"Gao","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2021.11.017_bib37","doi-asserted-by":"crossref","first-page":"14448","DOI":"10.1038\/ncomms14448","article-title":"MVP-mediated exosomal sorting of miR-193a promotes colon cancer progression","volume":"8","author":"Teng","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2021.11.017_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12068","article-title":"Small extracellular vesicles deliver osteolytic effectors and mediate cancer-induced osteolysis in bone metastatic niche","volume":"10","author":"Ma","year":"2021","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.canlet.2021.11.017_bib39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41572-020-00216-3","article-title":"Bone metastases","volume":"6","author":"Coleman","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.canlet.2021.11.017_bib40","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10555-014-9494-4","article-title":"Integrating new discoveries into the \"vicious cycle\" paradigm of prostate to bone metastases","volume":"33","author":"Cook","year":"2014","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.canlet.2021.11.017_bib41","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ccell.2015.04.009","article-title":"The TGF-\u03b2 signaling regulator PMEPA1 suppresses prostate cancer metastases to bone","volume":"27","author":"Fournier","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2021.11.017_bib42","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nm.1979","article-title":"TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation","volume":"15","author":"Tang","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2021.11.017_bib43","doi-asserted-by":"crossref","first-page":"9170","DOI":"10.1038\/srep09170","article-title":"ANGPTL2 increases bone metastasis of breast cancer cells through enhancing CXCR4 signaling","volume":"5","author":"Masuda","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2021.11.017_bib44","doi-asserted-by":"crossref","first-page":"6175","DOI":"10.1158\/1078-0432.CCR-14-0007","article-title":"Elevated serum angiopoietin-like protein 2 correlates with the metastatic properties of colorectal cancer: a serum biomarker for early diagnosis and recurrence","volume":"20","author":"Toiyama","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2021.11.017_bib45","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.bbrc.2018.07.065","article-title":"ANGPTL2 deletion inhibits osteoclast generation by modulating NF-\u03baB\/MAPKs\/Cyclin pathways","volume":"503","author":"Li","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438352100584X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438352100584X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T16:00:12Z","timestamp":1759593612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030438352100584X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":45,"alternative-id":["S030438352100584X"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2021.11.017","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-687415\/v1","asserted-by":"object"}]},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor-derived miR-378a-3p-containing extracellular vesicles promote osteolysis by activating the Dyrk1a\/Nfatc1\/Angptl2 axis for bone metastasis","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2021.11.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}